Skip to content

Insight Molecular Diagnostics Inc.: filings

Every Insight Molecular Diagnostics Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 42 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-10fiscal Q2 2026471330001642380-26-000011
10-Q2026-05-13fiscal Q1 202647960001642380-26-000008
10-K2026-03-26fiscal FY 2025501010001642380-26-000004
10-Q2025-11-10fiscal Q3 2025491390001193125-25-274266
10-Q2025-08-11fiscal Q2 2025491390000950170-25-106552
10-Q2025-05-12fiscal Q1 202549990000950170-25-069213
10-K2025-03-24fiscal FY 202450980000950170-25-043852
10-Q2024-11-12fiscal Q3 2024481330000950170-24-125365
10-Q2024-08-08fiscal Q2 2024451290001493152-24-030793
10-Q2024-05-15fiscal Q1 202443880001493152-24-019842
10-K2024-04-16fiscal FY 202347940001493152-24-014720
10-Q2023-11-09fiscal Q3 2023471320001493152-23-040121
10-Q2023-08-10fiscal Q2 2023481310001493152-23-027603
10-Q2023-05-15fiscal Q1 202347920001493152-23-016796
10-K2023-04-12fiscal FY 202250980001493152-23-012005
10-Q2022-11-10fiscal Q3 2022491300001493152-22-031415
10-Q2022-08-12fiscal Q2 2022501340001493152-22-022151
10-Q2022-05-12fiscal Q1 202248960001493152-22-013051
10-K2022-03-11fiscal FY 2021461650001493152-22-006677
10-Q2021-11-09fiscal Q3 2021441210001493152-21-027698
10-Q2021-08-11fiscal Q2 2021441210001493152-21-019327
10-Q2021-05-17fiscal Q1 202144900001493152-21-011836
10-K2021-03-19fiscal FY 202042750001493152-21-006465
10-Q2020-11-12fiscal Q3 2020451060001493152-20-021125
10-Q2020-07-29fiscal Q2 2020451080001493152-20-014178
10-Q2020-05-12fiscal Q1 202045820001493152-20-008385
10-K2020-03-26fiscal FY 201933630001493152-20-004738
10-Q2019-11-14fiscal Q3 201932820001493152-19-017464
10-Q2019-08-14fiscal Q2 201930800001493152-19-012536
10-Q2019-05-14fiscal Q1 201930620001493152-19-007082
10-K2019-04-01fiscal FY 201833640001493152-19-004549
10-Q2018-11-13fiscal Q3 201829730001493152-18-015756
10-Q2018-08-14fiscal Q2 201829730001493152-18-011807
10-Q2018-05-15fiscal Q1 201830600001493152-18-007134
10-K2018-04-02fiscal FY 201734870001140361-18-016477
10-Q2017-11-14fiscal Q3 201729800001140361-17-042789
10-Q2017-08-14fiscal Q2 201729760001140361-17-032097
10-Q2017-04-28fiscal Q1 201727560001140361-17-017245
10-K2017-02-27fiscal FY 201630770001140361-17-009369
10-Q2016-11-10fiscal Q3 201629780001140361-16-085842
10-Q2016-08-11fiscal Q2 201628720001140361-16-075892
10-Q2016-05-16fiscal Q1 201628580001140361-16-065775

Inspect the source

Entity
Insight Molecular Diagnostics Inc. / CIK 0001642380
Captured
2026-09-21T17:22:58.445Z
SEC response SHA-256
0a6761cf94e28474363a8a78b49cfef33865938d1402e981fe1319a8439212bf

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001642380.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))